In line with these observations, SLC22A3 was reported as metastasis suppressor in familial esophageal squamous cell carcinoma where it directly inhibits ACTN4 (alpha actin 4, OMIM: 604638)17. Here, SLC22A3 is linked to esophageal squamous cell carcinoma.